Basit öğe kaydını göster

dc.contributor.authorSezer, A.
dc.contributor.authorOzyilkan, O.
dc.date.accessioned2020-10-20T09:02:57Z
dc.date.available2020-10-20T09:02:57Z
dc.date.issued2019
dc.identifier.issn1556-0864en_US
dc.identifier.urihttps://www.jto.org/article/S1556-0864(19)31849-0/pdf
dc.identifier.urihttp://hdl.handle.net/11727/4936
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.jtho.2019.08.1166en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectALK positiveen_US
dc.subjectROS1 positiveen_US
dc.subjectLorlatiniben_US
dc.subjectAdvanced stage lung canceren_US
dc.titleLorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkeyen_US
dc.typeconferenceObjecten_US
dc.relation.journalJOURNAL OF THORACIC ONCOLOGYen_US
dc.identifier.volume14en_US
dc.identifier.issue10en_US
dc.identifier.startpageS558en_US
dc.identifier.endpageS559en_US
dc.identifier.wos000492162203082en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster